ConductScience.org, home

Trial · NCT02635542

Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery

NCT02635542, Phase 4, Completed, University of Chicago; results first posted 2018-07-17

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery. Trials, record NCT02635542. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02635542

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery
NCT number
NCT02635542
Status
Completed
Phases
Phase 4
Enrollment
100 participants, actual
Lead sponsor
University of Chicago
Conditions
Neuromuscular Blockade, Postoperative Complications
Interventions
Succinylcholine, Cisatracurium
First posted
2015-12-21
Last updated
2018-07-17
Results first posted
2018-07-17

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants With Postoperative Pulmonary Complications72 hours following surgical procedure
Having at least one of the following complications, determined according to pre-specified criteria: extubation delayed \>24hrs, reintubation, mechanical respiratory support, pneumonia, aspiration, ARDS (Acute Respiratory Distress Syndrome), or mortality from respiratory arrest.
SecondarySurgical ConditionsDuring general anesthesiaAssessed by surgeon questionnaire designed for study to determine any negative effects impeding the progress of surgery or safety, on scale of 1=poor to 5=excellent

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Postoperative Pulmonary Complications72 hours following surgical procedureParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYSurgical ConditionsDuring general anesthesia2 participants in the CIS group and 4 participants in the SUX group had missing data for this outcome.units on a scaleMEAN

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Postoperative Pulmonary ComplicationsGroup CIS8Participants
Number of Participants With Postoperative Pulmonary ComplicationsGroup SUX8Participants
Surgical ConditionsGroup CIS4.96Standard Deviation 0.20units on a scale
Surgical ConditionsGroup SUX4.65Standard Deviation 0.85units on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDGroup CIS50
Overall StudySTARTEDGroup SUX50
Overall StudyCOMPLETEDGroup CIS50
Overall StudyCOMPLETEDGroup SUX50
Overall StudyNOT COMPLETEDGroup CIS0
Overall StudyNOT COMPLETEDGroup SUX0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityGroup CIS050
Total, all-cause mortalityGroup SUX050
Total, other adverse eventsGroup CIS050
Total, other adverse eventsGroup SUX050
Total, serious adverse eventsGroup CIS050
Total, serious adverse eventsGroup SUX050

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Group CIS vs Group SUX: Number of Participants With Postoperative Pulmonary ComplicationsTrial comparisons
Group CIS vs Group SUX: deaths from any causeTrial comparisons
Group CIS vs Group SUX: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02635542

GET https://conductscience.org/api/trials/v1/NCT02635542/registered